FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and deals with human oxyntomodulin, covalently bound with homopolymer polysaccharide, which contains 50 units of alpha-2,8 sialic acid, for treatment of hyperglycemia; a medication for treatment or prevention of hyperglycemia, which contains as an active substance an effective quantity of the said human oxyntomodulin; a method of treatment and prevention of hyperglycemia in a patient.
EFFECT: group of inventions provides the prolonged pharmacological effect and the high hypoglycemic activity in comparison with non-modified oxyntomodulin.
4 cl, 3 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG PREPARATION AND METHOD FOR IMPROVING RHEOLOGICAL PROPERTIES OF SPUTUM AND PULMONARY ADMINISTRATION OF THIS PREPARATION | 2009 |
|
RU2522846C2 |
| INHALATION DRUG FORM OF POLYSIALYLATED HUMAN DOEXYRIBONUCLEASE I AND METHOD OF OBTAINING THEREOF | 2010 |
|
RU2559522C2 |
| N-TAILED POLYSIALYLATION | 2007 |
|
RU2432175C2 |
| ALDEHYDE DERIVATIVES OF SIALIC ACID, METHODS OF THEIR OBTAINMENT, CONJUGATES OF ALDEHYDE DERIVATIVES OF SIALIC ACID, AND PHARMACEUTICAL COMPOSITION BASED ON THEM | 2004 |
|
RU2333223C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2732703C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2593960C2 |
| COMPOSITION FOR TREATING DIABETES, CONTAINING LONG-ACTING INSULIN CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | 2012 |
|
RU2606840C2 |
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING A POLYPEPTIDE | 2019 |
|
RU2777095C1 |
| ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
